A cell‐penetrating small peptide antagonizing MZF1‐AS1‐PARP1 interaction was potent in suppressing proline synthesis, tumorigenesis, and aggressiveness, suggesting a potential therapeutic approach for NB. This evidence concerns the gene PARP1 and neuroblastoma.